Eli Lilly

“It's Eli Lilly building a new plant.”

“Momentum shows up in named pharma partnerships (Novartis, Lilly, Johnson & Johnson), a mix of partnered and wholly owned programs, and the company's push to move internal assets toward the clinic.”

“About 80% of proteins in the human body are too slippery for traditional pills to target. Molecular glue is changing that, and Novartis, Roche, and Lilly have already committed billions to chase it.”